A comprehensive analysis of breast cancer microbiota and host gene expression
Open accessThe DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
The inflammatory tumoral-immune response alters the physiology of the tumor microenvironment, which may attenuate genomic instability. In addition to inducing inflammatory immune responses, several pathogenic bacteria produce genotoxins. However the extent of microbial contribution to the tumor microenvironment biology remains unknown. We utilized The Cancer Genome Atlas, (TCGA) breast cancer data to perform a novel experiment utilizing unmapped and mapped RNA sequencing read evidence to minimize laboratory costs and effort. Our objective was to characterize the microbiota and associate the microbiota with the tumor expression profiles, for 668 breast tumor tissues and 72 non-cancerous adjacent tissues. The prominent presence of Proteobacteria was increased in the tumor tissues and conversely Actinobacteria abundance increase in non-cancerous adjacent tissues. Further, geneset enrichment suggests Listeria spp to be associated with the expression profiles of genes involved with epithelial to mesenchymal transitions. Moreover, evidence suggests H. influenza may reside in the surrounding stromal material and was significantly associated with the proliferative pathways: G2M checkpoint, E2F transcription factors, and mitotic spindle assembly. In summary, further unraveling this complicated interplay should enable us to better diagnose and treat breast cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Intratumor bacteria have been reported in many tumor types (2-19)”
From The human tumor microbiome is composed of tumor type–specific intracellular bacteria (2020) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
vegan: Community Ecology Package
Oksanen, J., Simpson, G. L., Blanchet, F. G., Kindt, R., Legendre, P., Minchin, P. R., O'Hara, R. B., Solymos, P., Stevens, M. H. H., Szoecs, E., et al. (2001) · CRAN: Contributed Packages · doi:10.32614/cran.package.vegan · Cited by 22,615
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Silhouettes: A graphical aid to the interpretation and validation of cluster analysis
Rousseeuw, P. J. (1987) · Journal of Computational and Applied Mathematics · doi:10.1016/0377-0427(87)90125-7 · Cited by 21,392
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Cited by
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., et al. (2020) · Science · doi:10.1126/science.aay9189 · Cited by 2,464
Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer
Fu, A., Yao, B., Dong, T., Chen, Y., Yao, J., Liu, Y., Li, H., Bai, H., Liu, X., Zhang, Y., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.027 · Cited by 981
Self-citationBreast Cancer and Its Relationship with the Microbiota
Fernández, M. F., Reina-Pérez, I., Astorga, J. M., Rodríguez-Carrillo, A., Plaza-Díaz, J., & Fontana, L. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081747 · Cited by 350
“Proteobacteria also showed increased presence among tumor tissues, and Actinobacteria in non-cancerous adjacent tissues tissue samples [69].”
BackgroundMethodInfluentialMicrobiome—Microbial Metabolome—Cancer Cell Interactions in Breast Cancer—Familiar, but Unexplored
Mikó, E., Kovács, T., Sebő, É., Tóth, J., Csonka, T., Ujlaki, G., Sipos, A., Szabó, J., Méhes, G., & Bai, P. (2019) · Cells · doi:10.3390/cells8040293 · Cited by 220
Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment
Laborda-Illanes, A., Sanchez-Alcoholado, L., Dominguez-Recio, M. E., Jimenez-Rodriguez, B., Lavado, R., Comino-Méndez, I., Alba, E., & Queipo-Ortuño, M. I. (2020) · Cancers · doi:10.3390/cancers12092465 · Cited by 206
“, 2017 [28] Breast 668 tumor tissues (HER2+, ER+, TNC) and 72 normal adjacent tissues from The Cancer Genome Atlas (TCGA) Breast tumor tissues and normal adjacent tissues V3-V5 16S rRNA amplified sequencing data ↑Proteobacteria, Actinobacteria and Firmicutes in breast tissues.”
BackgroundMicrobiome and Breast Cancer: New Role for an Ancient Population
Eslami-S, Z., Majidzadeh-A, K., Halvaei, S., Babapirali, F., & Esmaeili, R. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00120 · Cited by 153
Chiba, A., Bawaneh, A., Velazquez, C., Clear, K. Y. J., Wilson, A. S., Howard-McNatt, M., Levine, E. A., Levi-Polyachenko, N., Yates-Alston, S. A., Diggle, S. P., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0451 · Cited by 144
“Noncancerous tumor adjacent tissue (n 1⁄4 72) and breast tumor (n 1⁄4 668) The Cancer Genome Atlas data were mined and nonoverlapping sequences were mapped to bacterial genomes (7).”
Costantini, L., Magno, S., Albanese, D., Donati, C., Molinari, R., Filippone, A., Masetti, R., & Merendino, N. (2018) · Scientific Reports · doi:10.1038/s41598-018-35329-z · Cited by 144
Current understanding of the intratumoral microbiome in various tumors
Xue, C., Chu, Q., Zheng, Q., Yuan, X., Su, Y., Bao, Z., Lu, J., & Li, L. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100884 · Cited by 135
“– Thompson et al.69 BC Proteobacteria The microbial community in breast tissue varied by race, stage, and breast tumor subtype.”
BackgroundInfluentialThe microbiome and cancer for clinicians
Picardo, S. L., Coburn, B. A., & Hansen, A. R. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.06.004 · Cited by 150
Ma, J., Huang, L., Hu, D., Zeng, S., Han, Y., & Shen, H. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02128-w · Cited by 153
Estrogens and the risk of breast cancer: A narrative review of literature
Al‐Shami, K., Awadi, S., Khamees, A., Alsheikh, A. M., Al-Sharif, S., Bereshy, R., Al-Eitan, S. F., Banikhaled, S. H., Al-Qudimat, A. R., Al‐Zoubi, R. M., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20224 · Cited by 180
“A shifting of microorganism types was estimated from the healthy breast tissue and cancerous including the presence of microorganisms that will raise the local breast estrogen exposure level by glucuronidation like S . pyogenes [155].”
Smith, A., Pierre, J. F., Makowski, L., Tolley, E. A., Lyn‐Cook, B. D., Lu, L., Vidal, G. A., & Starlard‐Davenport, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-48348-1 · Cited by 134
Costa, D. A., Nobre, J. G., Batista, M. V., Ribeiro, C., Callé, C., Cortés, A., Marhold, M., Negreiros, I., Borralho, P., Brito, M., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.584332 · Cited by 140
An overview of cancer health disparities: new approaches and insights and why they matter
Minas, T. Z., Kiely, M., Ajao, A., & Ambs, S. (2021) · Carcinogenesis · doi:10.1093/carcin/bgaa121 · Cited by 115
“Previously, the microbiome of breast tumors has been described from TCGA data but a separate analysis of African American tumors was not performed (200).”
MethodWang, Y., Guo, H., Gao, X., & Wang, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754788 · Cited by 128
“In the study of a TCGA breast cancer cohort, the results indicated an increased Proteobacteria presence in tumor tissues, while the composition ofActinobacteriawas elevated in the adjacent normal tissues (15).”
BackgroundDiet Alters Entero-Mammary Signaling to Regulate the Breast Microbiome and Tumorigenesis
Soto‐Pantoja, D. R., Gaber, M. K., Arnone, A. A., Bronson, S. M., Cruz‐Diaz, N., Wilson, A. S., Clear, K. Y. J., Ramirez, M. U., Kucera, G. L., Levine, E. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2983 · Cited by 102
Gut Microbiota and Breast Cancer: The Dual Role of Microbes
Álvarez‐Mercado, A. I., Cano, A. D. V., Fernández, M. F., & Fontana, L. (2023) · Cancers · doi:10.3390/cancers15020443 · Cited by 105
“Study Sampling Materialsand Site Microbiota Detection and OTU Picking Method Sample Size Main Findings Chiba, A. et al., 2019 [77] Snap-frozen breast tumor tissue.”
BackgroundInfluentialThe Emerging Role of the Microbiota in Breast Cancer Progression
Bernardo, G., Noci, V. L., Modica, M. D., Montanari, E., Triulzi, T., Pupa, S. M., Tagliabue, E., Sommariva, M., & Sfondrini, L. (2023) · Cells · doi:10.3390/cells12151945 · Cited by 93
“Moreover, in a study of 668 breast tumor tissues present in The Cancer Genome Atlas (TCGA) data set, the microbiome profile was correlated with the expression of specific tumor genes [64].”
BackgroundVergara, D., Simeone, P., Damato, M., Maffia, M., Lanuti, P., & Trerotola, M. (2019) · Journal of Oncology · doi:10.1155/2019/1253727 · Cited by 84
“Firmicutes Breast Staphylococcus: detrimental, linked to development of breast cancer Lactobacillus: beneficial [37, 43]”
BackgroundMicrobiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity
Sipe, L. M., Chaib, M., Pingili, A. K., Pierre, J. F., & Makowski, L. (2020) · Immunological Reviews · doi:10.1111/imr.12856 · Cited by 78
PLSDA-batch: a multivariate framework to correct for batch effects in microbiome data
Wang, Y., & Cao, K. L. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbac622 · Cited by 77
Statistical normalization methods in microbiome data with application to microbiome cancer research
Xia, Y. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2244139 · Cited by 83
“CQN was reported from breast cancer microbiota and host gene expression study to normalize the host gene expression counts.(129)”
BackgroundThe oncogenic roles of bacterial infections in development of cancer
Eyvazi, S., Vostakolaei, M. A., Dilmaghani, A., Borumandi, O., Hejazi, M. S., Kahroba, H., & Tarhriz, V. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104019 · Cited by 75
Gene therapy: A promising approach for breast cancer treatment
Dastjerd, N. T., Valibeik, A., Monfared, S. R., Goodarzi, G., Sarabi, M. M., Hajabdollahi, F., Maniati, M., Amri, J., & Tehrani, S. S. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3676 · Cited by 82
Role of the tumor microenvironment in cancer hallmarks and targeted therapy (Review)
Naser, R., Fakhoury, I., El‑Fouani, A., Abi‑Habib, R., & El‑Sibai, M. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5471 · Cited by 61
Microbial biomarkers of common tongue coatings in patients with gastric cancer
Xu, J., Xiang, C., Zhang, C., Xu, B., Wu, J., Wang, R., Yang, Y., Shi, L., Zhang, J., & Zhan, Z. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.11.051 · Cited by 60
Rodriguez, R. M., Hernandez, B. Y., Menor, M., Deng, Y., & Khadka, V. S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.003 · Cited by 61
“This study offered experimental validation via direct 16S rRNA sequencing of bacterial presence with samples from whom RNA sequencing data had initially been derived [26].”
BackgroundMethodThe onco-immunological implications of Fusobacterium nucleatum in breast cancer
van der Merwe, M., van Niekerk, G., Botha, A., & Engelbrecht, A. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.02.007 · Cited by 56
Modulating Microbiota as a New Strategy for Breast Cancer Prevention and Treatment
Wu, H., Ganguly, S., & Tollefsbol, T. O. (2022) · Microorganisms · doi:10.3390/microorganisms10091727 · Cited by 57
Human gut, breast, and oral microbiome in breast cancer: A systematic review and meta-analysis
Thu, M. S., Chotirosniramit, K., Nopsopon, T., Hirankarn, N., & Pongpirul, K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1144021 · Cited by 60
“Thompson 2017 – Case-control USA 740 – (18)”
MethodInfluentialJiang, S., Ma, W., Ma, C., Zhang, Z., Zhang, W., & Zhang, J. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2341717 · Cited by 57
“171 In the four BC subtypes, Proteobacteria and Actinomyces were also confirmed to be significantly enriched.”
BackgroundKovàcs, T., Mikó, E., Ujlaki, G., Yousef, H., Csontos, V., Uray, K., & Bai, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10013-3 · Cited by 57
“Listeria fleischmannii in the breast cancer oncobiome is associated with epithelial-to-mesenchymal transition [68].”
BackgroundInfluentialFu, Y., Li, J., Cai, W., Huang, Y., Liu, X., Ma, Z., Tang, Z., Bian, X., Zheng, J., Jiang, J., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.11.018 · Cited by 48
Dual Role of Bacteria in Carcinoma: Stimulation and Inhibition
Al-Hilu, S. A., & Al-Shujairi, W. H. (2020) · International Journal of Microbiology · doi:10.1155/2020/4639761 · Cited by 50
“Several studies showed the existence of diverse species of bacteria in breast tissue of healthy human [100] due to the favorable environment for the bacterial growth in breast by containing fatty tissue and extensive vasculature and lymphatic drainage [101]; these bacteria play important roles for supporting the devel…”
BackgroundSingla, R. K., Wang, X., Gundamaraju, R., Joon, S., Tsagkaris, C., Behzad, S., Khan, J., Gautam, R. K., Goyal, R., Rakmai, J., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2097196 · Cited by 57
“Breast milk microbiota influences breast dysbiosis which can also impact lactational mastitis further influencing infants’ overall growth (Thompson et al., 2017).”
BackgroundExploring the Potential of Breast Microbiota as Biomarker for Breast Cancer and Therapeutic Response
Dieleman, S., Aarnoutse, R., Ziemons, J., Kooreman, L. F. S., Boleij, A., & Smidt, M. L. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.02.020 · Cited by 50
“At the phylum level, highest presence of Proteobacteria was found in breast cancer tissue, compared with highest presence of Actinobacteria in adjacent normal breast tissue.(14) The families Pseudomonadaceae, Sphingomonadaceae, Alcaligenaceae, Ruminococcaceae, and Clostridia seemed to be decreased in adjacent breast t…”
BackgroundThe Relationship Between Microbial Community and Breast Cancer
Song, X., Wei, C., & Li, X. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.849022 · Cited by 47
“(Xuan et al., 2014) Breast tissue 668 tumor tissues (HER2+, ER+, TNC) and 72 normal adjacent tissues from The Cancer Genome Atlas (TCGA) V3-V5 16S rRNA amplified sequencing data ↑Proteobacteria, Actinobacteria and Firmicutes in breast tissues.”
BackgroundInfluentialThe conundrum of breast cancer and microbiome - A comprehensive review of the current evidence
Papakonstantinou, A., Nuciforo, P. G., Borrell, M., Zamora, E., Pimentel, I., Saura, C., & Oliveira, M. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102470 · Cited by 51
Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer
Malla, R. R., Marni, R., Kumari, S., Chakraborty, A., & Pappu, L. (2021) · Clinical Breast Cancer · doi:10.1016/j.clbc.2021.09.002 · Cited by 46
Microbiota composition in bilateral healthy breast tissue and breast tumors
Klann, E. M., Williamson, J. M., Tagliamonte, M. S., Ukhanova, M., Asirvatham, J. R., Chim, H., Yaghjyan, L., & Mai, V. (2020) · Cancer Causes & Control · doi:10.1007/s10552-020-01338-5 · Cited by 50
Dey, P., & Chaudhuri, S. R. (2022) · Biology · doi:10.3390/biology11050757 · Cited by 46
Zumwalde, N. A., Haag, J. D., Gould, M. N., & Gumperz, J. E. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1036-5 · Cited by 46
Hadžega, D., Minárik, G., Karaba, M., Kaľavská, K., Benca, J., Čierniková, S., Sedláčková, T., Nemcova, P., Boháč, M., Pinďák, D., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169058 · Cited by 40
“For example, Listeria fleischmannii showed to be associated with epithelial to mesenchymal transition [17].”
BackgroundResultHuang, X., Pan, T. S., Yan, L., Jin, T., Zhang, R., Chen, B., Feng, J., Duan, T., Yu, X., Zhang, M., et al. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.10.002 · Cited by 44
Maximizing the Utility of Cancer Transcriptomic Data
Xiang, Y., Ye, Y., Zhang, Z., & Han, L. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.09.009 · Cited by 40
E. coli Secretome Metabolically Modulates MDA-MB-231 Breast Cancer Cells’ Energy Metabolism
AlMalki, R. H., Sebaa, R., Al‐Ansari, M. M., Al-Alwan, M. M., Alwehaibi, M. A., & Rahman, A. M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044219 · Cited by 37
“Their findings showed abundant Mycobacterium fortuitum and Mycobacterium phlei in BC tissue compared to the normal adjacent tissue [28].”
BackgroundCirculating tumor cells clusters and their role in Breast cancer metastasis; a review of literature
Sayed, Z. S., Khattap, M. G., Madkour, M. A., Yasen, N. S., Elbary, H. A., Elsayed, R. A., Abdelkawy, D. A., Wadan, A. S., Omar, I., & Nafady, M. H. (2024) · Discover Oncology · doi:10.1007/s12672-024-00949-7 · Cited by 44
“Compared to other body regions, the bac‑ terial pattern seen in normal BC is distinct and includes Actinobacteria, Firmicutes, Proteobacteria, and Bacteroidetes [83–85].”
BackgroundYue, K., Sheng, D., Xue, X., Zhao, L., Zhao, G., Jin, C., & Zhang, L. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.00904-23 · Cited by 40
“examined both the presence of microbes and host expression from the same tissue/sample preparations by using The Cancer Genome Atlas (TCGA) breast cancer data and associated the microbiota with tumor expression profiles (14).”
MethodChiou, Y., Li, S., Ho, C., & Pan, M. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800392 · Cited by 34
Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment
Al‐Ansari, M. M., AlMalki, R. H., Dahabiyeh, L. A., & Rahman, A. M. A. (2021) · Metabolites · doi:10.3390/metabo11110758 · Cited by 36
“668 72 NGS V3–V5 ↑Mycobacterium fortuitum and Mycobacterium phlei [46]”
BackgroundLiao, K., Wen, J., Liu, Z., Zhang, B., Zhang, X., Fu, Y., Zhang, W., Hu, H., Ai, K., Zhu, W., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102820 · Cited by 40
Impact of intestinal dysbiosis on breast cancer metastasis and progression
Zhang, J., Xie, Q., Huo, X., Liu, Z., Da, M., Yuan, M., Zhao, Y. D., & Shen, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1037831 · Cited by 35
“(82) V3-V5 16S rRNA amplified sequencing data 668 tumor tissues and 72 normal adjacent tissues from The Cancer Genome Atlas (TCGA) ↑Actinobacteria and Firmicutes ↑Proteobacteria, Mycobacterium fortuitum and Mycobacterium phlei”
BackgroundBreast Cancer: Extracellular Matrix and Microbiome Interactions
Herrera‐Quintana, L., Vázquez‐Lorente, H., & Plaza‐Díaz, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137226 · Cited by 36
“…Fusobacterium nucleatum , Prevotella nigrescens , Streptococcus constellatus , Peptostreptococcus micros , Campylobacter showae , Eubacterium nodatum , Campy-lobacter gracilis , and Campylobacter rectus ) associated with periodontal disease have been identified in the orange complex [101,104,105].”
The intratumoural microbiota in cancer: new insights from inside
An, Y., Zhang, W., Liu, T., Wang, B., & Cao, H. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188626 · Cited by 29
The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
Modica, M. D., Arlotta, V., Sfondrini, L., Tagliabue, E., & Triulzi, T. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.947188 · Cited by 36
“, Haemophilus influenzae and Listeria fleischmannii) with genes that are expressed by tumor cells, such as those that are involved in EMT, and mediate the G2-M DNA damage checkpoint, E2F transcription, and mitotic spindle assembly pathways (56).”
BackgroundLocal Breast Microbiota: A “New” Player on the Block
Vitorino, M. M., Costa, D. A., Vicente, R. S., Caleça, T., & Santos, C. (2022) · Cancers · doi:10.3390/cancers14153811 · Cited by 30
“evaluated the RNA sequence to examine the microbiota in breast tissues and reported distinct bacteria, more Proteobacteria in tumour samples and Actinobacteria in normal tissues [63].”
BackgroundMicrobiomes, Their Function, and Cancer: How Metatranscriptomics Can Close the Knowledge Gap
Aitmanaitė, L., Širmonaitis, K., & Russo, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813786 · Cited by 30
“…a higher abundance of Listeria spp. has been found to be associated with the expression of genes involved in epithelial-to-mesenchymal transition (EMT), while that of Haemophilus influenzae was associated with proliferative pathways, including G2M checkpoints and E2F transcription factors [41].”
BackgroundThe Association Between Periodontal Disease and Breast Cancer in a Prospective Cohort Study
Jia, M., Wu, Z., Vogtmann, E., O’Brien, K. M., Weinberg, C. R., Sandler, D. P., & Gierach, G. L. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0018 · Cited by 33
Hawkins, G. M., Burkett, W. C., McCoy, A. N., Nichols, H. B., Olshan, A. F., Broaddus, R. R., Merker, J. D., Weissman, B. E., Brewster, W. R., Roach, J. M., et al. (2022) · Gynecologic Oncology · doi:10.1016/j.ygyno.2022.02.021 · Cited by 30
Understanding and harnessing triple-negative breast cancer-related microbiota in oncology
Devoy, C., Bueso, Y. F., & Tangney, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1020121 · Cited by 33
Intestinal vitamin D receptor protects against extraintestinal breast cancer tumorigenesis
Zhang, Y., Xia, Y., Zhang, J., Deb, S., Garrett, S., & Sun, J. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2202593 · Cited by 29
A comprehensive analysis of the microbiota composition and gene expression in colorectal cancer
Zhang, Q., Zhao, H., Wu, D., Cao, D., & Ma, W. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01938-w · Cited by 27
Toumazi, D., Daccache, S. E., & Constantinou, C. (2021) · Oncology Reports · doi:10.3892/or.2021.8031 · Cited by 32
Cancer and the Microbiome of the Human Body
Herrera‐Quintana, L., Vázquez‐Lorente, H., López-Garzón, M., Cortés‐Martín, A., & Plaza‐Díaz, J. (2024) · Nutrients · doi:10.3390/nu16162790 · Cited by 27
Intratumor microbiota: a novel tumor component
Gong, Y., Huang, X., Wang, M., & Liang, X. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04576-7 · Cited by 28
“In an analysis of lung microbiota from paired samples of tumor tissue and contralateral non-cancerous sites collected from 24 lung cancer patients and 18 healthy subjects, it was found that microbial diversity was significantly lower in lung cancer patients compared to controls, with Streptococcus spp. and Staphylococ…”
MethodInfluentialThe Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments
Son, Y. M., & Kim, J. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2208.08002 · Cited by 26
“Additionally, results obtained from the correlation analysis of expression profiles in samples from breast cancer patients show a strong association between Haemophilus influenzae and proliferation pathways genes, namely G2M checkpoint and E2F transcription factors [68].”
BackgroundFeng, K., Ren, F., & Wang, X. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1327893 · Cited by 29
“…red complex (Porphyromonas, Tannerella, and Treponema ) and the orange complex ( Fusobacterium , Prevotella, Peptostreptococcus , Streptococcus , Eubacterium, and Campylobacter ), are observed to have a heightened risk of breast cancer (Thompson et al., 2017; Wang et al., 2017; Huang et al., 2018).”
BackgroundMethodAmaro-da-Cruz, A., Rubio‐Tomás, T., & Álvarez‐Mercado, A. I. (2024) · Clinical & Translational Oncology · doi:10.1007/s12094-024-03554-w · Cited by 26
“[96].”
Interactions between the tumor microbiota and breast cancer
Guo, H. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1499203 · Cited by 29
“…from both breast cancer and normal breast tissues, but the relative abundance at the genus level is very different, the expression of these microbiota in breast cancer tissue is signi fi cantly increased (Urbaniak et al., 2014, 2016; Thompson et al., 2017; Nejman et al., 2020; Fu et al., 2022).”
Potential of the Microbiome as a Biomarker for Early Diagnosis and Prognosis of Breast Cancer
Jarman, R., Ribeiro-Milograna, S., & Kalle, W. H. J. (2020) · Journal of Breast Cancer · doi:10.4048/jbc.2020.23.e60 · Cited by 24
“[14] reported that postmenopausal estrogen metabolism seems to be influenced by the diversity of the microbiome, and higher circulating estrogen levels were found to be associated with microbiome dysbiosis in patients with a history of breast cancer.”
BackgroundBacteria Associated with Granulomatous Lobular Mastitis and the Potential for Personalized Therapy
Li, X.-Q., Wu, H., Yuan, J., Liu, T., Sun, S., & Chen, C. (2020) · Journal of Investigative Surgery · doi:10.1080/08941939.2020.1833262 · Cited by 22
“Two reports [17,18] described the endogenous microbiome”
Arnone, A. A., Tsai, Y.-T., Cline, J. M., Wilson, A. S., Westwood, B. M., Seger, M. E., Chiba, A., Howard-McNatt, M. M., Levine, E. A., Thomas, A., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101880 · Cited by 27
“15,16 These studies further suggest a potential link between tumor microbiota and cancer development.”
Borchmann, S. (2021) · Microbiome · doi:10.1186/s40168-021-01039-4 · Cited by 24
“were detected in breast cancer and adjacent tissue [34], while Escherichia sp.”
BackgroundAgents of cancer immunosurveillance: HSPs and dsDNA
Nayak, D. A., & Binder, R. J. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.03.004 · Cited by 23
Enhancing Targeted Therapy in Breast Cancer by Ultrasound-Responsive Nanocarriers
Edwards, I. A., Carlo, F. D., Sitta, J., Varner, W., Howard, C. M., & Claudio, P. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065474 · Cited by 22
The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME)
DiPalma, M. P., & Blattman, J. N. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1141215 · Cited by 24
“Further investigations are needed to determine if bacterial presence in cancer impacts cancer progression via changes in immune cell function or if metabolites preferred by certain bacteria that are present as a result of cancer progression provide a niche for those found in specific tumor tissues, the presence of par…”
BackgroundAn Update on the Potential Roles of E2F Family Members in Colorectal Cancer
Xu, Z., Qu, H., Ren, Y., Gong, Z., Ri, H., & Chen, X. (2021) · Cancer Management and Research · doi:10.2147/cmar.s320193 · Cited by 23
Gut microbiota in cancer initiation, development and therapy
Zhang, R., Zhang, X., Lau, H. C.-H., & Yu, J. Q. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2831-x · Cited by 19
“…analysis utilized RNA sequencing data from The Cancer Genome Atlas (TCGA), which included 668 tumor samples and 72 non-cancerous adjacent tissues, and observed significant shifts in microbial abundance, particularly an increase in Proteobacteria in tumor samples (Thompson et al., 2017).”
Is the skin microbiota a modifiable risk factor for breast disease?: A systematic review
Wang, K., Nakano, K., Naderi, N., Bajaj‐Elliott, M., & Mosahebi, A. (2021) · The Breast · doi:10.1016/j.breast.2021.07.014 · Cited by 24
Ujlaki, G., Kovács, T., Vida, A., Kókai, E., Rauch, B., Schwarcz, S., Mikó, E., Janka, E. A., Sipos, A., Hegedűs, C., et al. (2023) · Molecules · doi:10.3390/molecules28155898 · Cited by 24
Summer, M., Sajjad, A., Ali, S., & Hussain, T. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-03868-x · Cited by 22
“Proteobacteria are most frequently detected in tumor cells, whereas Actinobacteria are typically more abundant in healthy tissues (Thompson et al. 2017).”
New Developments and Opportunities of Microbiota in Treating Breast Cancers
Meng, Z., Ye, Z., Zhu, P., Zhu, J., Fang, S., Qiu, T., Li, Y., & Meng, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.818793 · Cited by 19
“Similarly, Streptococcus pyogenes was also reported to increase estrogen levels through β-glucuronidases activity in BC (Thompson et al., 2017).”
BackgroundThe microbiome: a link between obesity and breast cancer risk
Gaber, M. K., Arnone, A. A., Vidi, P., & Cook, K. L. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2024.1394719 · Cited by 21
Desalegn, Z., Smith, A., Yohannes, M., Cao, X., Anberber, E., Bekuretsion, Y., Assefa, M., Bauer, M., Vetter, M., Kantelhardt, E. J., et al. (2023) · Cancers · doi:10.3390/cancers15194893 · Cited by 18
“Studies suggest that pathophysiological changes occurring within the breast cells could have a significant impact on tumor growth [51].”
Rad, S. K., Yeo, K. K. L., Wu, F., Li, R., Nourmohammadi, S., Tomita, Y., Price, T. J., Ingman, W. V., Townsend, A. R., & Smith, E. (2025) · Microorganisms · doi:10.3390/microorganisms13020467 · Cited by 24
“Eleven lacked project accession numbers [14,18,21,23,24,26,27,32–34, 36 ],”
Qiu, Q., Lu, D., Liu, G., Yang, X., Li, J., Ren, H., Liu, J., Sun, B., & Zhang, Y. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00407 · Cited by 16
Social Isolation and Breast Cancer
Hilakivi-Clarke, L. A., & Andrade, F. D. O. (2023) · Endocrinology · doi:10.1210/endocr/bqad126 · Cited by 23
The intratumoral microbiota in breast cancer: from basic research to clinical translation
Xu, Y., & Wang, M. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2560695 · Cited by 22
“25,26 Spatial metabonomic studies have revealed that the concentration of lactic acid in areas enriched with Candida albicans increases 2.4-fold, potentially mediating local immunosuppression.”
InfluentialChronic inflammation evoked by pathogenic stimulus during carcinogenesis
Brücher, B. L. D. M., & Jamall, I. S. (2019) · 4open · doi:10.1051/fopen/2018006 · Cited by 19
Laborda-Illanes, A., Aranega-Martín, L., Sánchez‐Alcoholado, L., Boutriq, S., Plaza-Andrades, I. J., Peralta-Linero, J., Ruiz, G. G., Pajares, B., Álvarez, M., Alba, E., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137091 · Cited by 18
“Finally, Haemophilus influenzae was associated with genes representing crucial pathways for tumorigenesis, such as E2 signaling, G2M checkpoint, and mitotic spindle assembly in BC patients [30].”
BackgroundSalihoğlu, R., & Önal-Süzek, T. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.585556 · Cited by 16
“influenza is significantly correlated with genes in the G2M checkpoint, E2F transcription, and mitotic spindle assembly pathways (Thompson et al., 2017) (Table 1).”
BackgroundBody Microbiota and Its Relationship With Benign and Malignant Breast Tumors: A Systematic Review
Samkari, A., Alsulami, M., Bataweel, L. A., Altaifi, R., Altaifi, A., Saleem, A., Farsi, A., Iskanderani, O. F., Akeel, N. Y., Malibary, N., et al. (2022) · Cureus · doi:10.7759/cureus.25473 · Cited by 19
“DOI 10.7759/cureus.25473 2 of 11 Reference Type of study Aim Sample size Sample site within the breast Sample assessment methods Main findings Xuan et al. [18] Cross- sectional To investigate the potential role of microbiota in breast cancer 20 patients with estrogen receptor-positive breast cancer Normal adjacent tis…”
BackgroundResultInfluentialIntratumour microbiota modulates adrenocortical cancer responsiveness to mitotane
Cantini, G., Niccolai, E., Canu, L., Gloria, L. D., Baldi, S., Propato, A. P., Fei, L., Nannini, G., Puglisi, S., Nesi, G., et al. (2023) · Endocrine Related Cancer · doi:10.1530/erc-23-0094 · Cited by 14
Salivary Biomarkers in Breast Cancer: From Salivaomics to Salivaoncoomics
Bel’skaya, L. V., & Dyachenko, E. I. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2907253 · Cited by 16
“Pe-riodontal diseases caused by specific bacteria, such as Porphyromonas , Tannerella , Treponema , Fusobacterium , etc., contribute to an increased risk of breast cancer [130,131].”
BackgroundJiang, Z., Li, L., Chen, J., Wei, G., Ji, Y., Chen, X., Liu, J., & Huo, J.-G. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104946 · Cited by 15
Guideline for designing microbiome studies in neoplastic diseases
Mikó, E., Sipos, A., Tóth, E., Lehoczki, A., Fekete, M., Sebő, É., Kardos, G., & Bai, P. (2024) · GeroScience · doi:10.1007/s11357-024-01255-4 · Cited by 16
Tissue-associated microbial detection in cancer using human sequencing data
Rodriguez, R. M., Khadka, V. S., Menor, M., Hernandez, B. Y., & Deng, Y. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03831-9 · Cited by 14
Chemopreventive efficacy of oral curcumin: a prodrug hypothesis
Liu, G., Khanna, V., Kirtane, A. R., Grill, A. E., & Panyam, J. (2019) · The FASEB Journal · doi:10.1096/fj.201900166r · Cited by 13
“However, another recent study suggests that the tumor microbiome couldbe the sourceof this enzyme (32).”
BackgroundPeriodontitis as a Risk Factor for Breast Cancer – What We Know Till Date?
Issrani, R., Reddy, R. J., El‐Metwally, T. H., & Prabhu, N. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.10.3109 · Cited by 15
Metadata
- Authors
- Thompson, K. J., Ingle, J. N., Tang, X., Chia, N., Jeraldo, P. R., Walther-Antonio, M. R., Kandimalla, K. K., Johnson, S., Yao, J. Z., Harrington, S. C., Suman, V. J., Wang, L., Weinshilboum, R. L., Boughey, J. C., Kocher, J.-P., Nelson, H., Goetz, M. P., & Kalari, K. R.
- Affiliations
- Mayo Clinic (US)
- University of Minnesota (US)
- Corresponding author
- Kalari, Krishna R.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2017-11-30
- Volume
- 12
- Issue
- 11
- Pages
- e0188873
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC5708741
- OpenAlex
- W2771514310
- Cited by
- 183
- References
- 63
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 24 · 2023: 35 · 2022: 23 · 2021: 26 · 2020: 18 · 2019: 12 · 2018: 7
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Mayo Clinic (P50 CA116201)
- National Institutes of Health
- Center for Individualized Medicine, Mayo Clinic (P50CA116201)
- National Cancer Institute (P50CA116201)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, tumor microbiome, tumor microenvironment, host gene expression, Proteobacteria, actinobacteria, Listeria, epithelial-mesenchymal transition, Haemophilus influenzae, G2/M checkpoint, E2F transcription factors, mitotic spindle assembly, tumor-associated bacteria
- MeSH terms
- Breast Neoplasms, Female, Humans, RNA, Ribosomal, 16S, Gene Expression, Sequence Analysis, RNA, Proteobacteria, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.